Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Inflammation01:38

Inflammation

65.2K
Overview
65.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

871
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effects.

Journal of clinical lipidology·2026
Same author

A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants.

JACC. CardioOncology·2026
Same author

Severe HDL-C Deficiency Caused by Acquired LCAT Deficiency: A Case Report with Lipidomic Profiling and Anti-LCAT Autoantibody Detection.

Internal medicine (Tokyo, Japan)·2026
Same author

A large-scale visual survey of beef carcass lean and fat colors for digital beef quality management.

Meat science·2026
Same author

Real-world management and outcomes of venous thromboembolism in patients with cancer and limited life expectancy in the direct oral anticoagulant era: insights from the COMMAND VTE Registry-2.

Cardio-oncology (London, England)·2025
Same author

Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2.

Thrombosis and haemostasis·2025

Related Experiment Video

Updated: Apr 12, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.8K

Lipoprotein lipase and atherosclerosis.

Junji Kobayashi1, Hiroshi Mabuchi2

  • 1General Internal Medicine, Kanazawa Medical University, Uchinada, Daigaku, Ishikawa, Japan mary@kanazawa-med.ac.jp.

Annals of Clinical Biochemistry
|May 22, 2015
PubMed
Summary

Lipoprotein lipase (LPL) hydrolyzes triglycerides and may contribute to atherosclerosis. Studying LPL

Keywords:
Atherosclerosislipoprotein lipase

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.9K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

545

Related Experiment Videos

Last Updated: Apr 12, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.8K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.9K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

545

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Molecular Biology

Background:

  • Lipoprotein lipase (LPL) is crucial for triglyceride hydrolysis from triglyceride-rich lipoproteins.
  • Emerging evidence suggests LPL also mediates lipoprotein binding to receptors and may play a role in atherosclerosis.
  • Understanding LPL's role in cardiovascular disease is vital, but direct human studies are limited by the rarity of LPL deficiency.

Purpose of the Study:

  • To investigate the potential atherogenic role of lipoprotein lipase.
  • To explore alternative methods for studying LPL's impact on cardiovascular disease due to the rarity of LPL deficiency.
  • To examine the correlation between LPL and cardiovascular disease onset in large population studies and animal models.

Main Methods:

  • Investigating the correlation of lipoprotein lipase with cardiovascular disease onset in large, prospective, population-based cohort studies.
  • Utilizing animal models to explore the atherogenicity of lipoprotein lipase, particularly when expressed by macrophages.
  • Reviewing existing evidence on LPL's functions, including triglyceride hydrolysis and lipoprotein receptor binding.

Main Results:

  • Lipoprotein lipase plays a dual role in lipid metabolism, hydrolyzing triglycerides and facilitating lipoprotein binding.
  • Evidence suggests a potential atherogenic role for lipoprotein lipase.
  • Prospective cohort studies and animal models are valuable tools for investigating LPL's association with cardiovascular disease.

Conclusions:

  • Lipoprotein lipase's involvement in cardiovascular disease warrants further investigation.
  • Population-based prospective studies and animal models provide complementary approaches to understand LPL's atherogenic potential.
  • Further research is needed to fully elucidate the complex role of LPL in the development of atherosclerosis.